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ttps://doi.org/10.1016/j.ajpath.2019.07.015Macrophages are important for effective iron recycling and erythropoiesis, but they also play a crucial
role in wound healing, orchestrating tissue repair. Recently, we demonstrated a significant accu-
mulation of iron in healing wounds and a requirement of iron for effective repair. Herein, we sought
to determine the influence of iron on macrophage function in the context of wound healing.
Interestingly, wound macrophages extensively sequestered iron throughout healing, associated with
a prohealing M2 phenotype. In delayed healing diabetic mouse wounds, both macrophage polari-
zation and iron sequestration were impaired. In vitro studies revealed that iron promotes differen-
tiation, while skewing macrophages toward a hypersecretory M2-like polarization state. These
macrophages produced high levels of chemokine (C-C motif) ligands 17 and 22, promoting wound
reepithelialization and extracellular matrix deposition in a human ex vivo wound healing model.
Together, these findings reveal a novel, unappreciated role for iron in modulating macrophage
behavior to promote subsequent wound repair. These findings support therapeutic evaluation of iron
use to promote wound healing in the clinic. (Am J Pathol 2019, 189: 2196e2208; https://doi.org/
10.1016/j.ajpath.2019.07.015)Supported by an MRC (UK) industrial CASE Ph.D. Studentship grant
MR/M016307/1 (M.J.H.).
Disclosures: None declared.Macrophages play a crucial role in orchestrating the wound
healing response, fulfilling prodigiously versatile functions.1
Evolutionarily conserved receptors allow macrophages to
detect and phagocytose pathogenic organisms in early
repair,2,3 whereas their high plasticity makes them master
effector cells, able to regulate inflammation and drive tissue
repair.4 Most, but not all, wound macrophages originate
from circulating bone marrowederived monocytes. Once at
the site of injury, these cells undergo marked, yet transient,
morphologic and behavioral changes in response to the local
wound milieu.5,6 Traditionally, wound-derived macro-
phages are categorized into two main subsets: classically
activated (M1 stimulated) and alternatively activated (M2
stimulated1). However, the M2 repertoire has now
expanded,7 with macrophage polarization currently under-
stood to be a spectrum of phenotypes largely governed by
tissue status and environmental stimuli.8stigative Pathology. Published by Elsevier IncM1-stimulated macrophages are induced in early wound
repair by proinflammatory mediators, such as lipopolysac-
charides and interferon-g, driving inflammation by secreting
reactive oxygen species and proinflammatory cytokines (eg,
IL-1, IL-6, and tumor necrosis factor-a9). Wound progression
is then characterized by a switch to alternative activation (M2),
partly mediated by efferocytosis.10 M2-stimulated macro-
phages express anti-inflammatory markers (eg, IL-4, IL-10,
IL-13, and transforming growth factor-b111) and produce
arginase, a key mediator of effective wound repair.12
Furthermore, M2-polarized macrophages produce a myriad
of growth factors to facilitate reepithelialization, fibroplasia,
and angiogenesis.13 Together, these mechanisms promote the. All rights reserved.
Iron, Macrophages, and Wound Healingscavenging of debris, bacteria, and proinflammatory cells; and
they orchestrate reparative processes to allow wound
resolution.1
There is a clear existing association between iron and
macrophages in the context of erythropoiesis. Herein, Kupffer
cells and nurse macrophages coordinate iron to support
erythropoiesis,14 and splenic macrophages crucially recycle
iron from senescent erythrocytes.15 As iron is associated with
heme-containing proteins for oxygen transport and meta-
bolism, iron recycling and regulation by macrophages prevent
a range of iron-mediated pathologies.16 Indeed, mice with
macrophages lacking ferroportin (the only know intracellular
iron exporter) become anemic, with iron loading in the spleen
and liver and defective macrophage function.17 Thus, iron
must be tightly regulated within the body to maintain normal
physiology and avoid tissue pathology.
In the context of tissue repair, the cellular importance of
iron is less clear. We have recently shown a substantial,
previously unreported, accumulation of iron in the latter
stages of wound healing that is attenuated in pathologic
diabetic wounds.18 This supports preceding observations
that abnormal iron levels are associated with impaired
healing.19,20 Specifically, iron modulates fibroblast behavior
to promote healing via increased extracellular matrix (ECM)
deposition.18 The hypothesis of the current study is that iron
plays an important role in modulating macrophage behavior
to promote healing. Using a combination of in vitro and
ex vivo studies, we explore the effect of iron on macrophage
polarization, secretory profile, and ability to promote heal-
ing in a human ex vivo wound model. The data demonstrate
an important new role for iron in mediating macrophage
function and subsequent contribution to wound healing.
Materials and Methods
Animal Housing and Experimentation
Young (8- to 10-weekeold) female wild-type (C57/Bl6),
nondiabetic (NDb; Lepr/þ), and diabetic (Db; Lepr/) mice
were purchased from Envigo Ltd. (Huntingdon, Cambridge-
shire, UK) and housed at the University of Manchester
Biological Services Facility. Mice received food and water ad
libitum and were kept under a 12-hour light/dark cycle with
constant temperature and humidity. Regulated procedures
were performed according to UK Home Office regulations
under project license 70/8136. Two equidistant 6-mm dorsal
excisional wounds were made, as described previously.21
Normal skin (day 0) and excisional wounds were collected
and fixed in neutral-buffered formalin for histology.
Immunohistochemistry Staining
Paraffin sections were cut (5 mm thick), dewaxed in xylene,
and brought to water down an ethanol gradient. Antigen
retrieval was performed with citrate buffer (pH 6) before pri-
mary antibody incubation at 4C overnight. ForThe American Journal of Pathology - ajp.amjpathol.orgimmunofluorescence, anti-rabbit ferritin (clone EPR3004Y),
anti-mouse a-smooth muscle actin (clone 1A4; Abcam,
Cambridge, UK), and anti-rat Mac-3 (clone M3/84; BD Bio-
sciences, Reading, UK) were used at 5 mg/mL. Anti-rabbit
keratin 14 (clone Poly19053; Biolegend, San Diego, CA), anti-
mouse COL1A1 (clone 3G3), and anti-mouse COL3A1 (clone
C-6; Santa Cruz Biotechnology, Heidelberg, Germany) were
used at 1 mg/mL. Alexa Fluor 488econjugated (Mac-3, a-
smooth muscle actin, and COL1A1) and Alexa Fluor
594econjugated (ferritin, keratin 14, COL1A1, and COL3A1)
secondary antibodies were used at 10 mg/mL for 1 hour at
room temperature (all from Thermo Fisher Scientific, Paisley,
UK). Slides were mounted with Mowiol 488 (Sigma-Aldrich,
Dorset, UK) containing DAPI (Thermo Fisher Scientific).
Images were taken on an LSM710 laser scanning confocal
microscope (Carl Zeiss Ltd, Cambridge, UK) using a 20
objective and the 405-nm diode, 488-nm argon, and 561-nm
Dulbecco’s phosphate buffered saline lasers. Mac-3e, ferritin-,
and a-smooth muscle actinepositive cells were counted in
ImageJ software version 1.8.0 (NIH, Bethesda, MD; http://
imagej.nih.gov/ij). For immunoperoxidase staining, anti-rat
Mac-3 (above), anti-rabbit nitric oxide synthase 2, and anti-
goat arginase-1 antibodies (both from Santa Cruz Biotech-
nology) were used at 1 mg/mL and detected using appropriate
VECTASTAIN ELITE ABC kits and NovaRED peroxidase
substrate (Vector Laboratories, Peterborough, UK). Bright-
field images were obtained on a Nikon E400 microscope
(Nikon Instruments Inc., Melville, NY) and SPOT camera
(SPOT Imaging, Sterling Heights, MI). Cell counts were per-
formed in ImagePro-Plus version 6.3.0 (Media Cybernetics,
Cambridge, UK).
THP-1 Cell Culture
THP-1 cells (ATCC TIB-202; ATCC, Middlesex, UK) were
used as a human monocyte model.22 THP-1 cells were
grown in RPMI 1640 medium (Thermo Fisher Scientific)
with 10% heat-inactivated fetal bovine serum (Thermo
Fisher Scientific) and 1% penicillin-streptomycin solution
(Thermo Fisher Scientific).
THP-1 Cell Differentiation Experiments
Phorbol 12-myristate 13-acetate (PMA) was used at
200 ng/mL to induce differentiation in THP-1 cells. THP-1
cells were treated with or without PMA and iron in the form
of ferric ammonium citrate (FAC) at 10 and 100 mmol/L
concentrations. After 3 days of incubation, THP-1 cells
were collected for RNA (below) to assess the expression of
the differentiation markers, CD11b, CD14, CD36, and
CD54, via quantitative real-time PCR.23,24
THP-1 Cell Polarization Experiments
After PMA stimulation for 3 days to induce differentiation,
THP-1ederived macrophages (TDMs) were stimulated to2197
Wilkinson et alM1 (interferon-g and lipopolysaccharide) and M2 (IL-4 and
IL-13) states using reagents at 20 ng/mL concentration (all
from Thermo Fisher Scientific) or left unstimulated (M0
treatment group). For these polarization experiments, TDMs
were treated with FAC at the same time as adding cytokines.
TDMs were collected after 24 hours for quantitative real-
time PCR, immunocytochemistry (using ferritin antibody, as
above), and Western blot analysis.
Quantitative Real-Time PCR
Macrophages were collected in Ambion TRIzol reagent
(Thermo Fisher Scientific), and RNA was isolated using
phenol/chloroform.25 RNA was purified using the Ambion
PureLink Mini Kit (Thermo Fisher Scientific), as per man-
ufacturer’s instructions, and reverse transcribed with Bio-
script (Bioline, London, UK) and Random Primers
(Promega, Southampton, UK). Quantitative real-time PCR
was performed with 2 Takyon SYBR Green mastermix
(Eurogentec, Hampshire, UK) and a CFX Connect ther-
mocycler (Bio-Rad Laboratories, Hertfordshire, UK).
Primer sequences are provided in Table 1.
Adhesion and Zymography
THP-1 cell adhesion was assessed after PMA and FAC
stimulation (as per differentiation experiments). Herein,
wells were rinsed with Dulbecco’s phosphate-buffered sa-
line (Thermo Fisher Scientific) to remove nonadherent cells;
and CellTiter 96 AQueous One Solution (Promega) was
added to the wells, as per manufacturer’s guidelines.
Zymography was also performed on conditioned medium
(CM) collected from these THP-1 cells, as described






















Human skin was collected from theaters at Castle Hill Hos-
pital (Cottingham, Hull, UK) under local research ethics
committee (17/SC/0220) approval and full, informed patient
consent. Human dermal fibroblasts (HDFs) were isolated, as
previously described.21 HDFs were cultured in minimum
essential medium (Gibco, Thermo Fisher Scientific) in 2%
fetal bovine serum with FAC for 11 days. Cells were removed
(denuded) from the HDF-derived ECM with 20 mmol/L
ammonium hydroxide (Sigma-Aldrich) in 0.5% Triton X-100
in Dulbecco’s phosphate-buffered saline. Denuded ECM was
treated with 10 mg/mL DNAse (Sigma-Aldrich) and exten-
sively washed. THP-1 cells were seeded on this HDF-derived
ECM with or without 200 ng/mL PMA, left for 3 days, and
collected for differentiation assessment via quantitative real-
time PCR. Immunocytochemistry and Perls Prussian Blue
staining were performed on the HDF-derived ECM.
Ferrozine Assay
A ferrozine assay allowed for the detection of ferrous and
ferric iron.27 Denuded HDF-derived ECMwas scraped on ice
in 50 mmol/L NaOH containing 1%HALT protease inhibitor
cocktail (Thermo Fisher Scientific). HCl (10 mmol/L) was
added to each lysate with 200 mL iron-releasing reagent
(8.6% v/v HCl and 280 mmol/L KMnO4 in distilled water) for
2 hours at 60C. Standards of known concentrations of FAC
(100mmol/L, 10mmol/L, 1 mmol/L, 100 mmol/L, 10 mmol/L,
1 mmol/L, and 0 mmol/L) were prepared and incubated, as
described. Samples were cooled at room temperature, and 50
mL iron detection reagent (650 mmol/L ferrozine, 650 mmol/L
neocuproine, 2.8 mmol/L ammonium acetate, and 1 mmol/L
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Iron, Macrophages, and Wound Healingtemperature for 30 minutes. Collected supernatant was read
at 570 nm, and cellular iron concentration (in mmol/L) was
calculated from the FAC standard curve.Perls Prussian Blue Staining
Perls Prussian Blue staining was used to visualize iron de-
posits. HDFs were left on their deposited ECM or removed
from their ECM before staining. Plates were fixed (4%
formaldehyde solution) and incubated in a 50:50 solution of
5% (w/v) potassium ferricyanide (in distilled water; Sigma-
Aldrich) and 5% (v/v) hydrochloric acid for 10 minutes at
room temperature, then rinsed in distilled water20 before
imaging.Murine Bone Marrow Macrophage Culture
Bone marrow was isolated from NDb and Db mice with
Dulbecco’s modified Eagle’s medium (Gibco, Thermo Fisher
Scientific). Mononuclear phagocytes were differentiated to
macrophages with L929 (CCL-1; ATCC) CM, containing
macrophage colony-stimulating factor. Macrophages were
differentiated for 7 days, serum starved, and then stimulated.
Macrophages were left unstimulated (M0) or polarized to M1
or M2 states21 in the presence of FAC and left for 24 hours
before collecting for quantitative real-time PCR.Western Blot Analysis
Western blot analysis was performed on FAC-treated
polarized TDMs. Blots were probed with anti-mouse
ferritin (clone B-12; Santa Cruz Biotechnology) at 1
mg/mL concentration for 1 hour at room temperature and
detected with SuperSignal West Pico PLUS Chemilumi-
nescent Substrate (Thermo Fisher Scientific).Transwell Co-Culture
THP-1 cells were differentiated and polarized, as described
above, but in Transwell inserts (0.4 mm; Corning, Flintshire,
UK). After polarization, inserts were washed in Dulbecco’s
phosphate-buffered saline, to remove exogenous cytokines
and FAC, and transferred to plates seeded with primary HDFs.
THP-1 cellecontaining inserts were replaced with fresh
inserts after 3 days of culture. On day 6, Transwell inserts were
removed and HDFs were fixed and stained using anti-mouse
collagen type I primary antibody at 1 mg/mL concentration
(clone 3G3; Santa Cruz Biotechnology). Images were taken
via confocal microscopy (above) and analysis of collagen
production performed in ImageJ version 1.8.0. Quantitative
real-time PCR was also performed on HDFs after Transwell
co-culture.The American Journal of Pathology - ajp.amjpathol.orgProteome Profiler Chemokine Arrays
TDMs were polarized in the presence of FAC for 24 hours,
washed extensively, and then given fresh RPMI 1640 media
with no cytokines for 2 days. This medium was collected
and sterile filtered before performing Proteome Profiler
chemokine arrays (Biotechne, Oxford, UK), as per manu-
facturer’s instructions.
Human ex Vivo Wounding
Human skin was collected, as described above, and defatted
before washing in 2% (v/v) antibiotic-antimycotic solution
(Thermo Fisher Scientific). Partial-thickness wounds were
generated (2-mm diameter) in the center of 6-mmediameter
skin explants using sterile biopsy punches (Stiefel Labora-
tories, Research Triangle Park, NC).Woundswere cultured in
Petri dishes on a stack of two absorbent pads and a nitrocel-
lulose 0.22-mm membrane using Dulbecco’s modified Ea-
gle’smediumwith 10% fetal bovine serum and 1% antibiotic-
antimycotic solution.Woundswere treatedwith a vehicle (1%
bovine serum albumin plus 0.002% dimethyl sulfoxide), 100
nmol/L CCR4 antagonist (C 021 dihydrochloride), 50 ng/mL
CCL17, and/or 50 ng/mL CCL22 (R&D Systems, Oxford,
UK), applied topically every 2 days. Wounds were collected
in 4% neutral-buffered formalin 3 days after wounding for
histologic analysis.
Statistical Analysis
Means  SEM were used to present all data. One- and two-
way analyses of variance were performed where applicable,
with appropriate post-hoc analyses. Significancewas deduced
at P < 0.05. Statistical analysis was performed in GraphPad
Prism version 7.0 (GraphPad Software, San Diego, CA).
Results
Macrophages Accumulate Iron across a Murine Healing
Time Course
We previously demonstrated the temporal accumulation of
iron in wound repair.18 Herein, the cellular nature of this
accumulated iron (measured as bioavailable ferritin) was
assessed across a wound healing time course. Total ferritin
was significantly increased on day 3 (P < 0.001) and day 7
(P < 0.001) after injury (Figure 1, AeC), with a large
proportion of iron sequestration occurring in macrophages
(P < 0.001) (Figure 1D) and, to a lesser extent, a-smooth
muscle actinepositive fibroblasts (P < 0.05) (Figure 1E).
Of note, wound macrophage phenotype changes signifi-
cantly over this time frame; nitric oxide synthase 2epositive
(proinflammatory) macrophages peaked at day 3 after
injury, whereas arginase-1epositive (anti-inflammatory)
macrophages dominated at day 7 after injury (Supplemental
Figure S1). Hence, wound iron preferentially accumulated2199
Wilkinson et alin macrophages, predominately correlating with tissue
infiltration of prohealing (M2) macrophages.
Impaired Macrophage Iron Accumulation in Diabetic
Wounds Correlates with Altered Macrophage
Polarization
In both Db and NDb mouse wounds, ferritin increased at
day 3 (P < 0.01 and P < 0.05) and day 7 (P < 0.001 and
P < 0.01) after injury, respectively (Figure 2, A and B).
However, the absolute ferritin level was reduced in Db mice
at all time points examined, significant at day 7 after injury
(P < 0.05). Interestingly, although the proportion of wound
tissue ferritin-positive macrophages was approximately
equal between Db and NDb mice day 3 wounds, there was a
clear reduction in Db macrophage iron sequestration at day
7 after injury (Figure 2C). This reduced proportion of
ferritin-positive macrophages in day 7 Db wounds was even
more meaningful given that total macrophages (Figure 2E)
and nitric oxide synthase 2epositive cells (M1 macrophage
marker) (Figure 2F) were both increased in Db mouse
wounds. By contrast, wound arginase-1epositive cells (M22200macrophage marker) were reduced in day 7 Db versus NDb
wounds (P < 0.05) (Figure 2, D and G), mirroring ferritin-
positive macrophages (Figure 2C). Collectively, these data
reveal altered macrophage iron sequestration and polariza-
tion in Db wounds.Endogenous Iron or Iron-Rich Extracellular Matrix
Promotes Macrophage Differentiation
The tissue microenvironment drives monocyte to macro-
phage differentiation.5 We, thus, investigated the influence
of exogenous iron on macrophage differentiation in THP-1
cells in vitro. Herein, iron (100 mmol/L FAC) administration
significantly potentiated THP-1 monocyte differentiation in
response to PMA treatment, marked by enhanced expression
of the differentiation markers CD11b (P < 0.001), CD14
(P < 0.001), CD36, and CD54 (P < 0.001) (Figure 3,
AeD). FAC also increased cellular adhesion, a phenotypic
marker of differentiation (P < 0.001) (Figure 3E) and
significantly induced cellular matrix metalloproteinase 9
activity (P < 0.001) (Figure 3, F and G).Figure 1 Ferritin levels increase in a temporal
manner throughout wound healing, and macro-
phages are key in time-dependent iron sequestra-
tion. A: Full wound images demonstrating ferritin
(red) and a-smooth muscle actin (a-SMA) (green)
staining. DAPI indicates blue nuclei. Five regions in
the granulation tissue were analyzed (boxed
areas). B: Representative images from red boxed
areas in A. CeE: Ferritin-positive cells (C), ferritin-
positive macrophages (Mac-3; D), and ferritin-
positive fibroblasts (a-SMA; E) increase
throughout healing. Significance versus day 0 (C)
and day 1 (D and E). One-way analysis of variance
with Tukey post-hoc analysis was performed. Data
are expressed as means þ SEM (CeE). n Z 4 to 5
mice per group (AeE). ***P < 0.001 versus day 0;
yP < 0.05, yyyP < 0.001 versus day 3. Scale bars:
100 mm (A); 50 mm (B).
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Figure 2 Diabetic (Db) wound macrophages
show impaired ferritin sequestration and altered
polarization. A: Nondiabetic (NDb) and Db wounds
stained for macrophages (Mac-3; green) and
ferritin (red). DAPI indicates blue nuclei.
Arrows denote ferritin-positive macrophages. B
and C: Quantification of total ferritin-positive cells
(B) and ferritin-positive macrophages (C). D:
Immunoperoxidase staining for nitric oxide
synthase 2 (Nos-2) and arginase-1.
Arrows denote positive staining. EeG: Quantifi-
cation of wound macrophages (E), Nos-2epositive
macrophages (F) and arginase-1epositive macro-
phages (G). B, C, and EeG: P values (asterisks)
are given versus day 0 (B and C) or day 3 (EeG).
Two-way analysis of variance with Tukey post-hoc
analysis was performed. Data are expressed as
meansþ SEM (B, C, and EeG). nZ 3 to 5 mice per
group (AeG). *P < 0.05, **P < 0.01, and
***P < 0.001 versus day 0; yP < 0.05, yyP < 0.01,
and yyyP < 0.001 versus day 3. Scale barsZ 50 mm
(A and D).
Iron, Macrophages, and Wound HealingIn the wound environment, macrophages will be exposed
to iron deposited in the ECM; it was, therefore, tested how
ECM derived from FAC-treated HDFs influenced macro-
phage differentiation. HDFs treated with FAC deposited an
extensive ECM (Figure 3H) rich in iron, as demonstrated by
both Perls Prussian Blue staining (Figure 3I) and ferrozine
assay (Figure 3J). THP-1 monocytes were seeded onto this
denuded ECM and stimulated with PMA to induce differ-
entiation. Exposure to the iron-rich ECM significantly
increased expression of the differentiation markers CD11bThe American Journal of Pathology - ajp.amjpathol.org(P < 0.001), CD14 (P < 0.05), CD36 (P < 0.001), and
CD54 (Figure 3, KeN). Clearly, both exogenous iron
treatment and exposure to iron-rich ECM stimulate macro-
phage differentiation.
Iron Drives Cytokine-Stimulated Macrophages toward a
Prohealing Phenotype
FAC treatment (100 mmol/L) led to a significant decrease in
the M1 markers IL-1b (P < 0.01) (Figure 4A) and tumor2201
Figure 3 A high iron environment enhances phorbol 12-myristate 13-acetate (PMA)einduced differentiation in THP-1 macrophages (TDMs). TDMs were
treated with ferric ammonium citrate (FAC) at the same time as PMA stimulation for differentiation. AeD: CD11b (A), CD14 (B), CD36 (C), and CD54 (D) expression
(quantitative real-time PCR, normalized to no PMA, no FAC group). EeG: FAC treatment promotes adhesion (E) and matrix metalloproteinase 9 activity (F and G).
HeJ: Human dermal fibroblasts (HDFs) deposit extracellular matrix (ECM) high in collagens (green; H) and rich in iron, shown by Perls Prussian Blue staining (I)
and ferrozine assay (J). Arrows indicate blue iron deposits. I: Inset: intracellular iron sequestration. KeN: TDMs seeded onto FAC-treated HDF ECM display
increased expression (quantitative real-time PCR) of differentiation markers. Two-way analysis of variance with Tukey post-hoc analysis was performed. Data are
expressed as means þ SEM (AeE, G, and JeN). n Z 3 donors/3 independent experiments (AeN). *P < 0.05, ***P < 0.001 versus control, no FAC group;
yP < 0.05, yyP < 0.01, and yyyP < 0.001. Scale bar Z 50 mm (HeI). Original magnification, 20 (inset). A, control; B, 10 mmol/L FAC; C, 100 mmol/L FAC.
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Figure 4 Iron skews macrophages toward a prohealing state. THP-1 macrophages were treated with ferric ammonium citrate (FAC) for 24 hours before
quantitative real-time PCR for M1 [IL-1b and tumor necrosis factor (TNF)-a; A and B] and M2 (CCL17 and CCL22; C and D) markers. Nondiabetic (NDb) and
diabetic (Db) macrophage expression of Il-1b (E and I), Tnfa (F and J), Ccl17 (G and K), and Ccl22 (H and L). Normalized to M0, no FAC group. Two-way
analysis of variance with Tukey post-hoc analysis was performed. Data are expressed as means þ SEM (AeL). n Z 3 donors/3 independent experiments
(AeL). *P < 0.05, **P < 0.01, and ***P < 0.001 versus M0 group; yP < 0.05, yyP < 0.01, and yyyP < 0.001.
Iron, Macrophages, and Wound Healingnecrosis factor-a (P < 0.001) (Figure 4B) in M1-stimulated
TDMs, whereas the expression of the M2 markers CCL17
(P < 0.001) (Figure 4C) and CCL22 (P < 0.001)
(Figure 4D) was elevated in M2-stimulated TDMs after 100
mmol/L FAC. Similar effects were observed in NDb murine
bone marrowederived macrophages (BMDMs), where Il-1b
expression was reduced at both FAC concentrations
(P < 0.001) (Figure 4E). Db BMDMs were less responsive
to iron, with Il-1b expression only reduced by 100 mmol/L
FAC treatment (P < 0.05) (Figure 4I) whereas FAC treat-
ment modestly reduced Tnf in NDb and Db BMDMs
(Figure 4, J and L). Intriguingly, 100 mmol/L FAC treatment
elevated Ccl17 and Ccl22 in M0, M1, and M2 polarized
BMDMs from NDb and Db mice (Figure 4, G, H, K, and L).
Together, these data reveal that iron skews cytokine profiles
in both TDMs and BMDMs.
Iron-Loaded M2 Macrophages Secrete Factors that
Stimulate Extracellular Matrix Production
TDMs treated with 100 mmol/L FAC showed significantly
greater ferritin storage in M0 (P < 0.001) and M2
(P < 0.001) states (Figure 5, A and B) by immunohisto-
chemistry, and in all three activation states via Western blotThe American Journal of Pathology - ajp.amjpathol.organalysis (P < 0.01 to P < 0.001) (Figure 5C). For both
techniques, the highest levels of ferritin were observed in
100 mmol/L FACetreated M2-polarized TDMs. As mac-
rophages play a key role in ECM remodeling,28 a Transwell
co-culture approach was used to test the paracrine effects of
FAC-stimulated TDMs on HDF ECM production. Trans-
well co-culture of M2-stimulated FAC-treated TDMs
resulted in up-regulation of COL1A1 (P < 0.05)
(Figure 5D), COL1A2 (P < 0.001) (Figure 5E), and
COL3A1 (P < 0.05) (Figure 5F) expression in HDFs.
Collagen I protein levels were also highest in HDFs
co-cultured with M2-stimulated, FAC-treated TDMs
(P < 0.001) (Figure 5, G and H). Finally, CM from iron-
treated M2-polarized TDMs was profiled using chemokine
arrays to characterize secreted factors of interest (Figure 5I).
Herein, CM from M2-stimulated TDMs treated with 100
mmol/L FAC displayed higher levels of multiple chemo-
kines, including CCL17 and CCL22.
CCL17 and CCL22 Promote Healing and ECM Deposition
in Human ex Vivo Wound Repair
To test the biological significance of TDM-derived che-
mokines, an ex vivo wound model was used. Given that the2203
Figure 5 Iron-loaded THP-1 macrophages (TDMs) secrete factors that stimulate extracellular matrix production in human dermal fibroblasts (HDFs). AeC:
Ferric ammonium citrate (FAC)etreated TDMs show increased ferritin expression via immunocytochemistry (A and B) and Western blot analysis (C).
þFAC indicates 100 mmol/L. DeH: Transwell co-culture of these FAC pretreated TDMs with HDFs leads to up-regulation of COL1A1 (D), COL1A2 (E), and COL3A1
(F) via quantitative real-time PCR, and increased collagen I production via immunofluorescence (G and H), in HDFs. I: Antibody array demonstrates increased
production of chemokines in FAC-treated THP-1econditioned media. Two-way analysis of variance with Tukey post-hoc analysis was performed. Data are
expressed þ SEM (BeG). n Z 3 donors/3 independent experiments (AeI). **P < 0.01, ***P < 0.001 versus M0 group; yP < 0.05, yyP < 0.01, and
yyyP < 0.001. Scale bars Z 50 mm (A and H). CTCF, corrected total cell fluorescence.
Wilkinson et alCCL17-CCR4 receptor axis has previously been suggested
to be important for healing,29 CCL17, CCL22, and an
antagonist to their common receptor, CCR4,30 were applied
topically to human ex vivo wounds. Wound closure (re-
epithelialisation) was significantly increased after treatment
with CCL17 (P < 0.01) or CCL22 (P < 0.05) in isolation
and by a combination of both ligands (P < 0.001) (Figure 6,2204A and B). Although the CCR4 antagonist (C 021 dihydro-
chloride) had no direct effect on wound closure, it signifi-
cantly blocked the healing promoting effect of CCL17
(P < 0.05) and a combination of both ligands (P < 0.01).
Finally, CCL17 and CCL22 effects on ECM production
were evaluated. Collagen I and collagen III contents were
assessed from three regions close to the wound surfaceajp.amjpathol.org - The American Journal of Pathology
Figure 6 CCL17 and CCL22 promote healing during ex vivo human wound repair. A and B: Keratin 14 staining (KRT14; A) and quantification of reepithelialization
(% closure; B). Dotted lines demonstrate reepithelialization. C: Representative image of collagen (COL) immunofluorescence quantification from three regions of
each section (boxed areas). DeF: Quantification of collagen I and collagen III immunofluorescence (D) and representative immunofluorescence images (E and F).
One-way analysis of variancewith Tukey post-hoc analysis was performed. Data are expressed asmeansþ SEM (B andD). nZ 3 donors (AeF). *P< 0.05, **P< 0.01,
and ***P < 0.001 versus vehicle group. Scale barsZ 50 mm (A, C, E, and F). C021, CCR4 antagonist (C 021 dihydrochloride).
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Wilkinson et al(Figure 6C). Collagen I was significantly increased after
treatment with CCL17 (P < 0.05) or a combination of both
ligands (P < 0.05), an effect that was again reversed by
cotreatment with the antagonist, C 021 dihydrochloride
(Figure 6, D and E). Collagen III was significantly elevated
after treatment with both ligands alone and in combination
(P < 0.05), which was again blocked by the receptor
antagonist, C 021 dihydrochloride (Figure 6, D and F).
Together, these data reveal a novel, previously unappreci-
ated role for the macrophage-derived chemokines, CCL17
and CCL22, in promoting human wound reepithelialization
and matrix deposition.Discussion
Macrophages are closely associated with the biological
availability of iron. In addition to modulating heme storage
and erythrocyte recycling,16 they engulf damaged erythro-
cytes in the wound bed.20 Wound tissue macrophages pre-
sent with diverse phenotypes,31 yet how macrophage
behavior is influenced by the complex wound microenvi-
ronment remains far from clear. Herein, we present new
experimental findings linking iron modulation of macro-
phage behavior and the remodeling phase of wound repair.
We previously revealed temporal accumulation of iron in
late-stage wound repair.18 Indeed, this wound iron seques-
tration correlates with a macrophage switch to an anti-
inflammatory (M2) phenotype,32 which is impaired in Db
pathologic healing.33 Circulating monocytes differentiate
into macrophages in response to environmental cues,5
potentially including iron. In fact, iron deficiency reduces
CD14 expression in blood monocyteederived macro-
phage34 and heme iron mediates SPI-Ceinduced macro-
phage differentiation.15 In concurrence, the present study
revealed that exposure to high iron increased macrophage
differentiation, but also significantly extended this obser-
vation to demonstrate a role for iron in modulating macro-
phage polarization and chemokine secretion.
Macrophages are able to perform versatile functions with
high plasticity to allow effective repair. Functionally,
CD11b-specific35 and arginase-specific12 ablation leads to
delayed healing and excessive inflammation. This illustrates
not only the importance of macrophage presence, but also
effective temporal modulation of macrophage phenotype in
wound healing. Although not extensively characterized, the
late-stage M2 switch may be driven by degradation of M1
receptors36 and activation of STAT6 and peroxisome
proliferator-activated receptor-g.37 Herein, we show that
iron may also critically promote alternative activation by
reducing the expression of Il-1b and Tnf-a and up-
regulating the expression of CCL17 and CCL22.
The effect of iron on macrophage polarization and
phenotype appears to be context dependent. Heme uptake
by macrophages in the damaged spinal cord promotes M1-
driven inflammation in mice,38 whereas iron sequestration2206induced an M1 phenotype in raw246.7 macrophages.39 It
has even been suggested that sustained, iron-induced,
proinflammatory macrophages may contribute to delayed
healing by triggering fibroblast senescence.40,41 On the
contrary, in atherosclerotic plaques, hemoglobin-
haptoglobin complexes shifted macrophages toward an
M2 state both in vivo (higher CD163) and in vitro (increased
IL-10 and IL-1RA42). Likewise, high iron up-regulated M2
marker expression, and reduced proinflammatory cytokines,
in lipopolysaccharide-stimulated macrophages.43
M2 macrophages release a myriad of factors (eg, trans-
forming growth factor-b1) to promote reepithelialization,
fibroplasia, fibroblast differentiation,13 and ECM remodel-
ing.29 In the current study, it is shown, for the first time, that
iron treatment of macrophages significantly potentiated the
release of a range of chemokines, which promoted collagen
production in HDFs. M2 macrophage CM is known to
stimulate collagen 1 and collagen 3 production in fibroblasts
in vitro,44 but direct application of M2-stimulated BMDMs
did not alter Db healing in vivo.45 These new data suggest
that iron indirectly stimulates HDF ECM deposition via
modulation of macrophage behavior, with potential thera-
peutic application in pathologic healing.
The iron-treated M2 macrophage screen identified the
chemokines CCL17 and CCL22. Both CCL17 and CCL22
were shown to directly promote reepithelialization and
collagen deposition in a human ex vivo wound repair model.
This is in line with previous work in HaCaTs,46 fibro-
blasts,47 and fibrosis in vivo.48 CCL17 has also been shown
to promote wound closure and granulation tissue formation
in murine wounds in vivo.49 Curiously, Barros et al50
demonstrated improved healing in a CCR4/ type 1 dia-
betes mellitus model and in wild-type type 1 diabetes mel-
litus mice treated with anti-CCL17 and anti-CCL22
antibodies. Thus, future studies investigating macrophage
iron processing should be extended to address tissue- and
pathology-specific differences.
In summary, these new data demonstrate a key role for
iron in modulating macrophage responses to the wound
environment. Iron skewed macrophages toward an M2-like
state that produced a secretome highly enriched with ECM-
stimulating factors, including the chemokines, CCL17 and
CCL22. It is tempting to speculate that local iron adminis-
tration, perhaps targeted to the latter stages of wound
healing, could have clinical benefit. Further work is now
required to explore how wound iron manipulation can be
used as a conduit to improve skin healing pathology.Acknowledgments
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